A detailed history of Letko, Brosseau & Associates Inc transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 45,300 shares of MGTX stock, worth $293,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,300
Previous 45,300 -0.0%
Holding current value
$293,544
Previous $190,000 1.05%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$4.21 - $5.81 $53,046 - $73,206
12,600 Added 38.53%
45,300 $190,000
Q4 2023

Feb 12, 2024

BUY
$3.6 - $7.15 $36,000 - $71,500
10,000 Added 44.05%
32,700 $229,000
Q3 2023

Nov 09, 2023

BUY
$4.79 - $7.19 $108,733 - $163,213
22,700 New
22,700 $111,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.